Further investigation into the mechanism of the lipid-lowering effects of ECD revealed that it downregulated ACSL4, ACSL1, CPT1A, and FASN levels in colorectal tissues and downregulated tumor formation in the colorectum. Here, FASN is linked to neoplasm.